Pharmaceutical Suppositories Market 2024 - By Size, Share, Forecast And Trends Analysis Report 2033

The new report published by The Business Research Company, titled Pharmaceutical Suppositories Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the pharmaceutical suppositories market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The pharmaceutical suppositories market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=8804&type=smp

Catalyst For Pharmaceutical Suppositories Market Growth
The increasing prevalence of diseases is expected to propel the pharmaceutical suppositories market going forward. The prevalence of diseases is rising mainly due to factors such as geology and climate, and insects that transmit the agent. Pharmaceutical suppositories help treat the increasing number of patients with various diseases due to the increasing prevalence of diseases. A pharmaceutical suppository is an additional drug delivery method that inserts a small, cylindrical, or conical device into the body, usually into the bottom which dissolves or melts releasing the drug to cure the disease. For instance, according to the report by the Australian Institute of health and welfare, over 4,700 hospitalizations were reported to have COVID-19 infection in 2020-2021. Viral pneumonia (24% of cases), 'COVID-19 infection' (19%), and symptoms including cough (9.9%), fever (6.6%), and breathing problems (4.8%) were the most frequent primary diagnoses recorded alongside other infectious diseases. Therefore, the increasing prevalence of diseases is driving the growth of the pharmaceutical suppositories market.

Transforming The Pharmaceutical Suppositories Market
Technological advancements are a key trend gaining popularity in the pharmaceutical suppositories market. Major companies operating in the pharmaceutical suppositories market are using advanced technologies to sustain their position in the pharmaceutical suppositories market. For instance, in March 2021, CB21 Pharma, a subsidiary of CB*Depot, a US-based manufacturer and B2B provider of high-end can*nabis products, launched CANNEFF VAG SUP vaginal suppositories and CANNEFF SUP rectal suppositories. CANNEFF VAG SUP is used for further therapy for the healing of atrophic and dystrophic vaginal mucous membrane disorders whereas CANNEFF SUP is utilized as a supplement to proctological procedures, proctitis, cryptitis, anal fissures, and perianal fistula to aid in the anorectal canal disorders' healing processes.

The pharmaceutical suppositories market covered in this report is segmented -

1) By Type: Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories, Other Types
2) By Base: Fatty Base, Water Miscible Bases, Emulsifying Bases
3) By End-User: Hospitals And Clinics, Nursing Homes, Home Care, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=8804&type=discount

Major companies operating in the pharmaceutical suppositories market report are Bayer AG, Pfizer Inc, Novartis International Ag, Sanofi S.A., Intas Pharmaceuticals Ltd,Unither Pharmaceuticals, Cosette Pharmaceuticals, Inc, Aenova Holding GmbH, Delpharm, Bliss GVS Pharma Ltd, JoinHub Pharma, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Divis Laboratories Ltd, Dr. Reddys Laboratories Ltd, Apollo Hospitals Enterprise Ltd, Torrent Pharmaceuticals Ltd, Amgen, Bristol Myers Squibb, Chiesi Farmaceutici, CSPC Pharmaceutical Group, Esteve Química, Humanwell Healthcare (Group) Co, Jiangsu Hengrui Pharmaceutical, GlaxoSmithKline (GSK), Nordic Pharma Group, Phoenix Pharma Group, DocMorris, Medpex, AstraZeneca, Abbott Laboratories, Mylan, Zentiva, Merck & Co, Teva Pharmaceutical Industries Ltd, AbbVie Inc, Apotex, Gilead Sciences, Roche, EMS Pharma, Biolab Farmaceutica, Boehringer Ingelheim, JRS Pharma, Roquette, Odan Laboratories Ltd, Axantia, Fresenius Kabi South Africa (Pty) Ltd, Kiara Health (Pty) Ltd, IBD Africa, Menarini Group, Padagis LLC

Contents of the report:
1. Executive Summary
2. Pharmaceutical Suppositories Market Report Structure
3. Pharmaceutical Suppositories Market Trends And Strategies
4. Pharmaceutical Suppositories Market - Macro Economic Scenario
5. Pharmaceutical Suppositories Market Size And Growth
…..
27. Pharmaceutical Suppositories Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/pharmaceutical-suppositories-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.